Sign in
4

Changes in Ownership

Fulcrum Therapeutics, Inc. Filed Acc 0001193125-26-037575

Options or other derivatives

  • Principal Accounting Officer acquired 57,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Tourangeau Greg · Principal Accounting Officer

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2026-02-02 Grant or award : show line 1 in the form Stock Option (right to buy) +57,000 57,000 D
Loading xslF345X05/ownership.xml…